• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SOLEVA PHARMA LLC MUGARD ORAL RINSE 240ML/BTL; DRESSING, WOUND AND BURN, HYDROGEL W/DRUG AND/OR BIOLOGIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SOLEVA PHARMA LLC MUGARD ORAL RINSE 240ML/BTL; DRESSING, WOUND AND BURN, HYDROGEL W/DRUG AND/OR BIOLOGIC Back to Search Results
Lot Number MV1040
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Insufficient Information (4580)
Event Date 06/07/2023
Event Type  Death  
Event Description
Event: (b)(6) at md office confirmed that the pt passed away on (b)(6) 2023.Gently swish and expel 5ml by mouth for 30-60 seconds or longer 4-6 times daily.Do not eat or drink for 1 hour after use.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MUGARD ORAL RINSE 240ML/BTL
Type of Device
DRESSING, WOUND AND BURN, HYDROGEL W/DRUG AND/OR BIOLOGIC
Manufacturer (Section D)
SOLEVA PHARMA LLC
MDR Report Key17135810
MDR Text Key317303307
Report NumberMW5118406
Device Sequence Number1
Product Code MGQ
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 06/12/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/14/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Lot NumberMV1040
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age82 YR
Patient SexMale
-
-